Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
639,503
-
Shares change
-
+80,688
-
Total reported value, excl. options
-
$86,947,170
-
Value change
-
+$11,080,521
-
Put/Call ratio
-
23%
-
Number of buys
-
21
-
Number of sells
-
-32
-
Price
-
$136.02
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2018
92 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q3 2018.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 639,503 shares
.
Largest 10 shareholders include ROYAL BANK OF CANADA (77,670 shares), UBS Group AG (68,289 shares), MORGAN STANLEY (61,700 shares), MURPHY CAPITAL MANAGEMENT INC (44,497 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (38,084 shares), Virtu Financial LLC (27,597 shares), Strategic Financial Services, Inc, (26,766 shares), COMMONWEALTH EQUITY SERVICES, LLC (17,975 shares), MOGY JOEL R INVESTMENT COUNSEL INC (17,365 shares), and RAYMOND JAMES & ASSOCIATES (17,130 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.